Please rotate your screen
apply for a license

A patient in the lab

HUB Organoids™ predict patient response to treatment.

Our technology allows the development of patient-derived “mini-organs in a dish” from both healthy and diseased tissues to close the gap between the lab and the clinic.

find out more
Select your tissue of interest
lungs
lungs
breast
breast
liver
liver
pancreas
pancreas
kidneys
kidneys
large intestines
large intestines
small intestines
small intestines
uterus
uterus
other
other
What is the purpose of use?
Academic use
Commercial use
What is the intended use?
Drug development
CRO
Biobanking
Equipment testing
Other use

Latest news

3D Tissue Models.png September 10, 2021

6th PREDiCT 3D Tissue Models

Meet our speaker Dr. Sylvia Boj discussing the next-gen models for…

read more
PERSIST-SEQ.png September 2, 2021

New PERSIST-SEQ program launched

2 September 2021, Utrecht (The Netherlands) - Hubrecht Organoid Technology (HUB) joins a new international…

read more
watch on demand (7).png September 1, 2021

2021 Organoids are us

New online presentation available on the use of HUB Organoids™ as a revolutionary approach to disease modeling, drug screening,…

read more
HBV infected liver organoid.jpg August 31, 2021

Link revealed between HBV infection and liver cancer

HUB Organoids derived from patients with chronic hepatitis B show the first molecular signs of liver cancer.

read more
partnership.png August 18, 2021

New service partnership

VANCOUVER, British Columbia - STEMCELL Technologies and Hubrecht Organoid Technology (HUB) have announced that…

read more
Cystic fibrosis organoid swelling.png August 12, 2021

CF models for drug development

HUB Organoids™ supports the on-going clinical evaluation of ELX-02 as a therapeutic agent for cystic fibrosis (CF)

read more
Jove paper.png August 5, 2021

Test epithelial barrier function

Discover the development of a new model to assess drug safety, absorption, methabolism, transport, and permeability.

read more
watch on demand (4).png July 28, 2021

Model human diseases and select treatment

Our CEO Dr. Rob Vries discusses how HUB Organoids help modelling human disease and select best treatement options

read more
Sylvia Boj_Corning.png July 27, 2021

Model inflammation in a dish

Watch Dr. Sylvia Boj discussing how HUB Organoids accelerate the development of new therapeutics for inflammatory diseases.

read more
Copy of HUB News (6).png July 14, 2021

HUB at Innovation Parade

HUB takes centre stage during this year’s Olympic games in Tokyo by sponsoring the …

read more
News and Insights infographics.png April 26, 2021

HUB and Yamaha for IVD

April 26, 2021 - Hubrecht Organoid Technology (HUB) and Yamaha Motor Co., Ltd.…

read more
Next-gen diagnostic center.png September 4, 2020

Next-gen diagnostics

Utrecht and Qingdao, Sep 4th, 2020 – Hubrecht Organoid Technology (HUB) and BGI-Qingdao announced…

read more
virtual panel discussion.jpg July 20, 2020

Organoids for infectious disease

During this virtual mini-symposium co-hosted with our partner STEMCELL Technologies we discuss the development and…

read more
Ovarian cancer organoids May 27, 2020

Ovarian cancer organoids

Researchers from the group of Hans Clevers at the Hubrecht Institute have modeled the development and progression of high-grade…

read more
intestine hormones.png May 13, 2020

Understanding gut’s hormones

Hormone-producing cells in the human gut are difficult to study, as they are very rare and unique to different species of…

read more
SARS-COV-2 COVID 19 May 1, 2020

SARS-CoV-2 infects gut cells

Researchers from the Hubrecht Institute in Utrecht, Erasmus MC University Medical Center Rotterdam, and Maastricht University in…

read more
Message CEO Covid.png April 1, 2020

A message from our CEO

Dear Valued Customer,

On Wednesday 11th March the World Health Organization (WHO) declared a pandemic in response to…

read more
genetic disease organoids.png February 20, 2020

Organoids for genetic disorders

Whereas the CRISPR/Cas9 technology cuts out a defect in a gene and replaces it with a new piece, the latest CRISPR technology…

read more
Tumor organoids Financial Times.png December 10, 2019

HUB on Financial Times

On December 10, 2019 the Financial Times featured HUB Organoids™ in …

read more
tumor-organoids-drug-discovery.png October 17, 2019

PDX organoids in drug development

San Diego, October 17, 2019 – Crown Bioscience today announced the launch of a new tumor organoid drug development platform…

read more
Organoids on a chip.png October 1, 2019

Organoids-on-a-chip

Leiden, Utrecht September 2019 - MIMETAS and Hubrecht Organoid Technology (HUB) announce that they entered into…

read more
toxicology-organoids.png July 16, 2019

Epistem license HUB Technology

Manchester, 16th July, 2019 - Epistem Limited, the UK based pre-clinical and clinical research services company…

read more
PDOs available at CrownBio.png May 19, 2019

HUB PDOs now at CrownBio

San Diego, Calif – May 19, 2020 — Crown Bioscience today announced the expansion of their unique organoid…

read more
research group.png April 9, 2019

New partner: CrownBio

March 27, 2019 – Hubrecht Organoid Technology (HUB) and JSR…

read more
Yamaha Cell handler organoids.png February 1, 2019

New partner: Yamaha Motor

February 1, 2019 – Hubrecht Organoid Technology (HUB) and Yamaha Motor Co., Ltd. (Tokyo:7272) announced today their…

read more

Want to know more?

Please contact us at +31 (0)88 12 36 300 or email us info@huborganoids.nl or drop us a message via the button below.

contact us
  • Yalelaan 62
  • 3584 CM Utrecht
  • The Netherlands